Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Classificação em ações #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Preço da ação
$0.2488447
Última sincronização: 2024-10-01
Valor de mercado
$2.01M
Variação (1 dia)
-1.88%
Variação (1 ano)
0.00%
País
IN
Negociar Ortin Laboratories Limited (ORTINLAB)

Categoria

EPS de Ortin Laboratories Limited (ORTINLAB)
EPS em June 2024 TTM: $-0.12
De acordo com os últimos relatórios financeiros e o preço das ações da Ortin Laboratories Limited, o EPS atual da empresa (TTM) é $-0.12. No final de 2023, a empresa teve um EPS de $0.00, um aumento em relação a ao EPS de 2022, que foi de $-0.01.
Histórico de EPS da Ortin Laboratories Limited de 2008 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.12 0.33%
2024 $-0.12 11,760.00%
2023 0.00 -84.62%
2022 $-0.01 -141.14%
2021 $0.02 -271.74%
2020 $-0.01 -140.71%
2019 $0.02 75.19%
2018 $0.01 32.99%
2017 $0.01 -37.01%
2016 $0.02 -12.50%
2015 $0.02 -27.87%
2014 $0.02 -0.41%
2013 $0.02 -20.45%
2012 $0.03 -57.75%
2011 $0.07 -29.90%
2010 $0.10 49.21%
2009 $0.07 -46.67%
2008 $0.13 0.00%
EPS de empresas semelhantes ou concorrentes